Peritoneal dialysis in patients with diabetes: Are the benefits greater than the disadvantages?

Peritoneal Dialysis International

Volumn 27, Issue SUPPL. 2, 2007, Pages

  Kuriyama, Satoru ^a  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

Diabetes; Diabetic retinopathy; Icodextrin; Survival

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; ICODEXTRIN; INSULIN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG TRANSPORT; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; KIDNEY FAILURE; OBESITY; PERITONEAL DIALYSIS; PERMEABILITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

DIABETIC NEPHROPATHIES; DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 35748949895     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. USRDS 1999 Annual Data Report. Am J Kidney Dis 1999; 34(Suppl 1):S1-176.
2. Patient Registration Committee, Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan (as of Dec. 31, 2004) [Japanese]. Tokyo: Japanese Society for Dialysis Therapy; 2005.
3. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 1983; 19:397-403.
4. Cancarini GC, Brunori G, Camerini C, Brasa S, Manilli L, Majorca R. Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 1986; 6:77-9.
5. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37:598-604.
6. Lang SM, Bergner A, Topfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int 2001; 21: 52-7.
7. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-53.
8. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-99.
9. Sato K, Babazono T. CAPD in diabetic patients. Clin Dialy 2000;16:2137-42.
10. Woodrow G. Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients? Perit Dial Int 2005; 25:230-3.
11. Kuriyama S. A potential role of peritoneal dialysis as "a bridging therapy" to other renal replacement therapies. Nephron 2001; 87:99-105.
12. Passadakis P, Oreopoulos D. Peritoneal dialysis in diabetic patients. Adv Ren Replace Ther 2001, 8:22-41.
13. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
14. Held PJ, Port FK, Turenne N, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patients mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163-9.
15. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
16. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10:354-65.
17. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17:112-17.
18. Schaubel DE, Morrison HI, Fenton SS. Comparing mortality rates on CAPD/ CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int 1998; 18:478-84.
19. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003; 14:2851-60.
20. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34:1065-74.
21. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66:2389-401.
22. U.S. Renal Data System. Excerpts from the USRDS 2000 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2000; 36(Suppl 1): S1-239.
23. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Stratification of risk for progression of kidney disease and development of cardiovascular disease. Am J Kidney Dis 2002; 39(Suppl 1):S170-212.
24. Nakayama M, Kawaguchi Y, for the Water and Etectrolyte Balance (WEB) Study Group in CAPD. Multi-center survey on hydration status and control of brood pressure in Japanese CAPD patients. Perit Dial Int 2002; 22:411-14.
25. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and salt removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
26. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
27. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD outcome study. J Am Soc Nephrol 2003; 14:2948-57.
28. Paniagua R, Ventura MJ, Avila M, Orihuela O, Cineros A, Vicente M, et al. Icodextrin-based solutions for peritoneal dialysis in diabetic patients with high-average and high peritoneal transport type. Results from a randomized controlled trial [Abstract]. Perit Dial Int 2006; 26(Suppl 2):S29.
29. Wolfson M, Piraino B, Hamburger RJ, Morton AR, for the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.